HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alterations in cellular energy metabolism associated with the antiproliferative effects of the ATM inhibitor KU-55933 and with metformin.

Abstract
KU-55933 is a specific inhibitor of the kinase activity of the protein encoded by Ataxia telangiectasia mutated (ATM), an important tumor suppressor gene with key roles in DNA repair. Unexpectedly for an inhibitor of a tumor suppressor gene, KU-55933 reduces proliferation. In view of prior preliminary evidence suggesting defective mitochondrial function in cells of patients with Ataxia Telangiectasia (AT), we examined energy metabolism of cells treated with KU-55933. The compound increased AMPK activation, glucose uptake and lactate production while reducing mitochondrial membrane potential and coupled respiration. The stimulation of glycolysis by KU-55933 did not fully compensate for the reduction in mitochondrial functions, leading to decreased cellular ATP levels and energy stress. These actions are similar to those previously described for the biguanide metformin, a partial inhibitor of respiratory complex I. Both compounds decreased mitochondrial coupled respiration and reduced cellular concentrations of fumarate, malate, citrate, and alpha-ketogluterate. Succinate levels were increased by KU-55933 levels and decreased by metformin, indicating that the effects of ATM inhibition and metformin are not identical. These observations suggest a role for ATM in mitochondrial function and show that both KU-55933 and metformin perturb the TCA cycle as well as oxidative phosphorylation.
AuthorsMahvash Zakikhani, Miguel Bazile, Sina Hashemi, Shiva Javeshghani, Daina Avizonis, Julie St Pierre, Michael N Pollak
JournalPloS one (PLoS One) Vol. 7 Issue 11 Pg. e49513 ( 2012) ISSN: 1932-6203 [Electronic] United States
PMID23185347 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • 2-morpholin-4-yl-6-thianthren-1-yl-pyran-4-one
  • Antineoplastic Agents
  • Cell Cycle Proteins
  • DNA-Binding Proteins
  • Fumarates
  • Hypoglycemic Agents
  • Ketoglutaric Acids
  • Malates
  • Morpholines
  • Pyrones
  • Tumor Suppressor Proteins
  • Citric Acid
  • malic acid
  • Metformin
  • Succinic Acid
  • ATM protein, human
  • Ataxia Telangiectasia Mutated Proteins
  • Protein Serine-Threonine Kinases
Topics
  • Antineoplastic Agents (pharmacology)
  • Ataxia Telangiectasia Mutated Proteins
  • Cell Cycle Proteins (metabolism)
  • Cell Line, Tumor
  • Cell Proliferation
  • Citric Acid (chemistry)
  • Citric Acid Cycle
  • DNA-Binding Proteins (metabolism)
  • Fumarates (chemistry)
  • HeLa Cells
  • Hep G2 Cells
  • Humans
  • Hypoglycemic Agents (pharmacology)
  • Ketoglutaric Acids (chemistry)
  • Malates (chemistry)
  • Membrane Potential, Mitochondrial
  • Metformin (metabolism, pharmacology)
  • Morpholines (pharmacology)
  • Oxygen Consumption
  • Phosphorylation
  • Protein Serine-Threonine Kinases (metabolism)
  • Pyrones (pharmacology)
  • Succinic Acid (chemistry)
  • Tumor Suppressor Proteins (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: